Espr stocktwits.

52 Week Low Date 10/12/23. Market Cap 359.861M. Shares Out 189.40M. 10 Day Average Volume 5.82M. Dividend -. Dividend Yield -. Beta 0.88. YTD % Change -36.45.

Espr stocktwits. Things To Know About Espr stocktwits.

americanbankingnews.com - May 1 at 3:18 AM. Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Tuesday. marketbeat.com - April 30 at 11:47 AM. Esperion Therapeutics, Inc. (NASDAQ:ESPR) Expected to Post FY2025 Earnings of $0.02 Per Share. marketbeat.com - April 30 at 8:31 AM. Esperion (ESPR) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Firefox only (Windows/Mac/Linux): Ever wish you could quickly grab every pic on a web site you're visiting? Firefox extension Save Images saves all linked images to a folder, with ...On Friday 04/26/2024 the closing price of the Esperion Therapeutics Inc share was $1.93 on BTT. Compared to the opening price on Friday 04/26/2024 on BTT of $2.01, this is a drop of 4.15% ...

Track EPR Properties (EPR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Find the latest Esperion Therapeutics, Inc. (ESPR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Track Solid Power Inc - Ordinary Shares - Class A (SLDP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

ETFs Holding ESPR. Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical ...A number of research firms have commented on ESPR. Needham & Company LLC reiterated a “buy” rating and set a $8.00 target price on shares of Esperion Therapeutics in a research report on ...

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin …Esperion Therapeutics, Inc. (ESPR): $2.76. 0.03 (-1.03%) POWR Rating. Get Rating. Component Grades. Growth. ... Featured Post From StockTwits About ESPREvernote is one of our favorite multipurpose note-taking tools, so it's not surprising that so many apps out there work with it. These apps do everything from using Evernote for st...Track Esperion Therapeutics Inc. (ESPR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsamericanbankingnews.com - May 1 at 3:18 AM. Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Tuesday. marketbeat.com - April 30 at 11:47 AM. Esperion Therapeutics, Inc. (NASDAQ:ESPR) Expected to Post FY2025 Earnings of $0.02 Per Share. marketbeat.com - April 30 at 8:31 AM.

Esperion (NASDAQ:ESPR) is an interesting bioscience that piqued our interest due to the strong insider purchases. A member of Integrated BioSci Investing (“IBI”) also requested us to conduct a ...

Get ratings and reviews for the top 7 home warranty companies in Lawton, OK. Helping you find the best home warranty companies for the job. Expert Advice On Improving Your Home All...

Symbol Company Name Industry Market Cap; A: Agilent Technologies Inc. Medical Specialties: 40643.7979: A2ZINFRA-NSE: A2Z Infra Engineering Ltd. Engineering And Construction This biopharmaceutical company is expected to post quarterly loss of $0.53 per share in its upcoming report, which represents a year-over-year change of +30.3%. Revenues are expected to be $26.84 million, up 42.6% from the year-ago quarter. Estimate Revisions Trend. Feb-24-23 01:40PM. Esperion Launches New Scientific Website. (GlobeNewswire) +6.35%. Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET …ESPR has been under attack by short sellers that plague social media, the short interest is over 20% of the float. Analysts rating ESPR are standing firm, Needham reiterated Strong Buy with $9 ...Rhea-AI Summary. Esperion (ESPR) reports strong financial growth in FY23 with U.S. net product revenue up 40% Y/Y to $78.3 million. Q4 U.S. net product revenue grew 39% Y/Y to $20.8 million. The company resolved litigation, receiving $100 million and potential cost savings. Positive interactions with FDA and EMA for cardiovascular indications.Founded. 2010. Website. verastem.com. Employees. 73. Get the latest Verastem Inc (VSTM) real-time quote, historical performance, charts, and other financial information to help you make more ...Dec 7, 2023 · Esperion Q3 Earnings & Revenues Beat Estimates. Esperion incurred a loss of 37 cents per share in the third quarter of 2023, narrower than the Zacks Consensus Estimate of a loss of 42 cents. The ...

Track Shopify Inc (SHOP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack RiverNorth/DoubleLine Strategic opportunity fund Inc (OPP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsLooking up an HP laptop model number based on a serial number is easy to do using an online tool provided by HP. If you have access only to a list of serial numbers for your compan...Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...Track ESP Resources, Inc. (ESPI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsEsperion (ESPR) In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Esperion, with a price target of $22.00. The company’s shares closed last Tuesday at $1.42 ...Track Surf Air Mobility Inc (SRFM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Esperion Therapeutics, Inc NASDAQ: ESPR is a pharmaceutical company focused on developing and commercializing oral, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Esperion’s products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Headquarters: 3891 Ranchero Dr, …

Apr 26, 2024 · A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ESPR has been under attack by short sellers that plague social media, the short interest is over 20% of the float. Analysts rating ESPR are standing firm, Needham reiterated Strong Buy with $9 ...Symbol Company Name Industry Market Cap; A: Agilent Technologies Inc. Medical Specialties: 40866.5197: A2ZINFRA-NSE: A2Z Infra Engineering Ltd. Engineering And ConstructionA number of research firms have commented on ESPR. Needham & Company LLC reiterated a “buy” rating and set a $8.00 target price on shares of Esperion Therapeutics in a research report on ...11.74. +1.43%. Find the latest Esperion Therapeutics, Inc. (ESPR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Find the latest Esperion Therapeutics, Inc. (ESPR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.ESPR (Esperion Therapeutics) short position ESPR (Esperion Therapeutics) short position Entry level: $7.93 Take profit: $6.82 Stop loss: $8.48. by UnknownUnicorn29970036. Oct 25, 2022. 2. Preparing for Earnings Season: ESPR Stocks that are reporting earnings in 3 to 4 weeks can be monitored for pre-earnings runs.Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -21.54% and 15.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? 27.15%. BEAT. Q2'23. $0.42. $0.45. 6.89%. BEAT. Checkout Etsy Inc (ETSY) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether ETSY beat the street expectations or not? Esperion Q3 Earnings & Revenues Beat Estimates. Esperion incurred a loss of 37 cents per share in the third quarter of 2023, narrower than the Zacks Consensus Estimate of a loss of 42 cents. The ...

A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Find the latest Esperion Therapeutics, Inc. (ESPR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The 1930-1940s Other Motorcycle Manufacturers Channel explores early models from lesser-known motorcycle makers. See these vintage motorcycles at HowStuffWorks. Advertisement The 1... Complete Esperion Therapeutics Inc. stock information by Barron's. View real-time ESPR stock price and news, along with industry-best analysis. ANN ARBOR, Mich., February 27, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update. “We have recently made major strides as a company, which we believe position us for sustained growth in the short, medium, and …ESPR has been under attack by short sellers that plague social media, the short interest is over 20% of the float. Analysts rating ESPR are standing firm, Needham reiterated Strong Buy with $9 ... Feb-24-23 01:40PM. Esperion Launches New Scientific Website. (GlobeNewswire) +6.35%. Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid ... Esperion Therapeutics, Inc. ( NASDAQ: ESPR) Q1 2023 Earnings Conference Call May 9, 2023 8:00 AM ET. Company Participants. Tiffany Aldrich - Associate Director, Corporate Communications. Sheldon ... Links ESPR StockTwits. Show Market Indexes. Detailed Chart. Chart Settings. About Candlesticks Basic Bullish Bearish. Default zoom . 125% rec. 24th April 2024 17:23 Top 10 Most Discussed Stocks On Stock Twits. Click on Bars to see the comments

Esperion Therapeutics - ESPR - Stock Price Today - Zacks. Esperion Therapeutics (ESPR) (Delayed Data from NSDQ) $2.04 USD. +0.07 (3.55%) Updated …Esperion Therapeutics, Inc NASDAQ: ESPR is a pharmaceutical company focused on developing and commercializing oral, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Esperion’s products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Headquarters: 3891 Ranchero Dr, Ann Arbor, MI 48108 ... 52 Week Low Date 10/12/23. Market Cap 359.861M. Shares Out 189.40M. 10 Day Average Volume 5.82M. Dividend -. Dividend Yield -. Beta 0.88. YTD % Change -36.45. Instagram:https://instagram. infiniti p0420how to tame a carcharodontosauruscooperstown dreams park new york 28 cooperstown nyhow to redeem warthunder codes The Esperion Therapeutics stock price fell by -4.52% on the last day (Friday, 26th Apr 2024) from $1.99 to $1.90. During the last trading day the stock fluctuated 6.91% from a day low at $1.88 to a day high of $2.01. The price has fallen in 6 of the last 10 days and is down by -11.21% for this period. Volume fell on the last day along with the ... highway 87 san jose newsthe wayans brother died Esperion (ESPR) Bank of America Securities analyst Jason Zemansky reiterated a Hold rating on Esperion on March 22 and set a price target of $2.90. The company’s shares closed last Friday at $2.29. Find the latest Esperion Therapeutics, Inc. (ESPR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. hibbett murfreesboro tn : Get the latest Hindustan Composites stock price and detailed information including news, historical charts and realtime prices. Indices Commodities Currencies StocksLoopring Foundation is a blockchain research organization building protocols, infrastructure, and user-facing DeFi products for the future of finance.Esperion (ESPR) reports mixed first-quarter 2023 results, wherein earnings miss and revenues beat estimates. The stock of the company surges 5% on Tuesday. The company maintains 2023 guidance.